PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $37.9 million in its second quarter.

On a per-share basis, the Pleasanton, California-based company said it had a loss of 32 cents.

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.

The life science technology company posted revenue of $153.1 million in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $150.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG